Convatec Technologies Inc.
USPTO PatentsView assignee record - 106 granted patents across 44 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, Convatec ranks #3,474 of 49,997 tracked US assignees by granted-patent volume, with 106 patents across 44 technology areas.
- #3,474
- of 49,997 US assignees by volume
- Top 7%
- by Innovation Score (54.7/100)
- 17.0
- avg claims per patent
- +29%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R3474 · US Corporation #3,474 · 106 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL
- GRANTS-MID 106 grants
- TOP-DECILE #3,474/49,997
- PHOTO-FINISH Aston Martin Lagonda
- CPC-WIDE A61F · 44 areas
- INNOV-PAR 54.7/100
- CLAIMS-RICH 17.0 claims/avg
- TYPE-USCORP US Corporation
- VEL-UP +29% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Aston Martin Lagonda Limited (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Convatec’s 54.7 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Convatec
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Amadeus S · near
Amadeus S · near
55 score
- Convatec · this assignee
Convatec · this assignee
55 score
- K2M · near
K2M · near
55 score
- Sumitomo Precision… · near
Sumitomo Precision… · near
55 score
- Otter Products · near
Otter Products · near
55 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Convatec's Innovation Score is 54.7/100 (top 7% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Convatec?
Each dot is one of Convatec’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Convatec’s own 17.0 claims/patent is at or below the 17.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Convatec's grants concentrate
Convatec Technologies Inc. is a focused PatentsView assignee: 44 CPC subclasses with 67% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2020 (14 grants) versus a trough of 3 in 2015. By volume, Convatec sits between Aston Martin Lagonda Limited and Festool GMBH.
Convatec's three-year grant acceleration
From 2019–2021 to 2022–2024, Convatec Technologies Inc. moved from 38 to 28 grants (0.74x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,027. See the growth leaderboard.
Who files at Convatec's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Aston Martin Lago…
Aston Martin Lagonda Limited
106 patents
- Atheer
Atheer, Inc.
106 patents
- Brookhaven Scienc…
Brookhaven Science Associates, LLC
106 patents
- Chongqing Univers…
Chongqing University
106 patents
- Charles Schwab &
Charles Schwab & Co., Inc.
106 patents
- Colorado School o…
Colorado School of Mines
106 patents
- FCI USA
FCI USA LLC
106 patents
- Festool
Festool GMBH
106 patents
- Convatec ◀
Convatec Technologies Inc.
106 patents
What this shows Convatec holds 106 patents at rank #3,472, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Convatec
By rank, the assignees closest to #3,472 in granted patent volume.
- Aston Martin Lagonda Limited #3,468 · 106 patents
- Atheer, Inc. #3,469 · 106 patents
- Brookhaven Science Associates, LLC #3,470 · 106 patents
- Chongqing University #3,471 · 106 patents
- Charles Schwab & Co., Inc. #3,473 · 106 patents
- Colorado School of Mines #3,474 · 106 patents
- FCI USA LLC #3,475 · 106 patents
- Festool GMBH #3,476 · 106 patents
Leaders in A61F (Filters Implantable Into Blood Vessels)
Other assignees with the most granted patents in Convatec's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- DePuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- Cook Medical Technologies LLC 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien LP 528 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Convatec, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Convatec ranks #82 of 3,082 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (55 here).
Similar claim depth
Nearest assignees by average claims per patent (17.0 here).
Convatec's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
55 Top 7% higher than 93% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 2.8% |
| 2016 | 8 | 7.5% |
| 2017 | 10 | 9.4% |
| 2018 | 7 | 6.6% |
| 2019 | 13 | 12.3% |
| 2020 | 14 | 13.2% |
| 2021 | 11 | 10.4% |
| 2022 | 6 | 5.7% |
| 2023 | 11 | 10.4% |
| 2024 | 11 | 10.4% |
| 2025partial year | 12 | 11.3% |
Which technologies does Convatec Technologies Inc. patent most?
Top 15 of 44 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Convatec Technologies Inc.'s patent record in context - here's where to go next.
- Convatec Technologies Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 67% of its portfolio - see every assignee active in that class. Explore A61F
- Ranked #3,474 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Convatec Technologies Inc. against Aston Martin Lagonda Limited, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 54.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.